Infraglottic Devices Market Outlook (2022-2033)

Rising Prevalence of Airway Disorder

The increased prevalence of respiratory disorders such as chronic obstructive pulmonary disorder (COPD), asthma, and acute respiratory distress syndrome (ARDS) influences the use of infraglottic products. Patients with such disorders may suffer from impaired breathing, and they might need mechanical ventilation. Tracheostomy and endotracheal tubes play an important role in keeping the airways patent and in ensuring that the oxygen reaches its destination. With the increasing prevalence of respiratory disorders among all age groups, the number of patients requiring admission to the ICU has risen.

However, acute emergencies, including infections, injuries, and post-surgery patients, have been identified as other causes of an increasing number of admissions into critical care units. Patients who need respiratory support for a prolonged period require tracheostomy tubes, which are safer and more sustainable when compared to endotracheal tubes. There is increased adoption of advanced devices that are developed to reduce complications associated with respiratory support, such as airway injury and aspiration, ensuring maximum comfort for the patient throughout the treatment process. Efforts to reduce morbidity and mortality rates have emphasized infraglottic devices in today's health sector. With the prevalence of respiratory ailments increasing, there will always be a need for reliable airway management, ensuring the growth of the market.

Development of Advanced and Patient-Friendly Devices

Manufacturers are innovating with devices in ways that allow easier insertions of devices, cause less trauma to the patient upon insertion, and increase patient comfort during long-term ventilation. Innovations of modern infraglottic devices include an improved cuff material to cause fewer pressure-related injuries, antimicrobial coating on the cuff to reduce the risk of infection and an enhanced flexibility of the tube to conform to each patient's anatomy to provide the best possible care in critical care settings where patients may be dependent on the airway device for a longer period of time and receive continuous ventilation. Devices are being customized to specific groups, such as pediatrics or geriatrics, using different sizes, materials, or design considerations for those populations, providing safety and effectiveness based on clinical scenarios.

Healthcare professionals are using equipment that is compatible with sophisticated monitoring systems and ventilators to enable better control and improve results. By concentrating on lowering the hazards associated with procedures such as airway damage and inhalation, there is an emphasis on achieving higher levels of safety and effectiveness in healthcare settings. With the increasing emphasis on providing patient-focused care across healthcare organizations, the need for technologically advanced infraglottic equipment is likely to grow. While this enhances the quality of patient outcomes, it makes the task easier for healthcare practitioners who can manage their patients' respiratory conditions.

The "Infraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Infraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• Infraglottic Devices market trends, as well as drivers, restraints, and opportunities
• Infraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Infraglottic Devices market
• Detailed company profiles, including SWOT analysis

The geographical scope of the infraglottic devices market report is divided into: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America held the largest share in 2025.

North America enjoys supremacy over other regions because of the developed health infrastructure and the presence of various respiratory problems. Infraglottic devices are extensively required owing to the availability of an effective medical facility and hospitals, which include critical care facilities and ambulance services. Healthcare technology is adopted extensively in the US and Canada owing to their focus on patient safety. Leading market players present in North America make sure to incorporate the latest developments in the product design and technology used.

High healthcare expenditures enable healthcare facilities to purchase advanced products in airway management. An increase in the number of surgeries and patients admitted to ICUs drives the need for tracheostomy and endotracheal tubes. Manufacturers are developing safer and more efficient medical devices that cause fewer risks and minimize patient discomfort. Although Asia Pacific emerges as a rapidly growing market because of improving healthcare infrastructure and increased awareness, the dominant position of North America will be ensured due to the mentioned factors.

• The report includes qualitative and quantitative data in the Infraglottic Devices market across product type, product design, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Infraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Infraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, and future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Infraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover the Infraglottic Devices market segments by product type, product design, application, patient type, end user, and geography across North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the Infraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The infraglottic devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Infraglottic Devices market are:

• In February 2024, Medtronic plc announced the US launch of the SonarMed airway monitoring system, designed to provide real-time detection of endotracheal tube obstruction and position, improving safety in ventilated patients.
• In January 2023, ICU Medical Inc. announced that it had completed the acquisition of Smiths Medical from Smiths Group plc, expanding its portfolio of endotracheal tubes, tracheostomy products, and other airway management devices.
• In October 2022, Ambu A/S announced the expansion of its single-use endoscopy portfolio, including solutions supporting airway management and intubation procedures, strengthening its presence in critical care settings.